AAV.php.b-husod1-sgrna

AAV.php.b-husod1-sgrna has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 1, 2022: “In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on AAV.php.b-husod1-sgrna

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Biogen
  • 3 of 3 findings with company ties
  • Animals1

What did studies of AAV.php.b-husod1-sgrna find?

3

Studies of AAV.php.b-husod1-sgrna measured 3 outcomes: lifespan, motor function and SOD1.

Lifespan

upin mice1

1 study
  1. AAV.php.b-husod1-sgrna extends lifespan in neonatal H11Cas9 SOD1G93A mice (>110 days).

    “extending lifespan by more than 110 days”

    Animalsin neonatal H11Cas9 SOD1G93A miceintracerebroventricular injection

    In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

    Gene therapy

Motor function

upin mice1

1 study
  1. AAV.php.b-husod1-sgrna improves motor function in neonatal H11Cas9 SOD1G93A mice.

    “restored motor function”

    Animalsin neonatal H11Cas9 SOD1G93A miceintracerebroventricular injection

    In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

    Gene therapy

SOD1

downin mice1

1 study
  1. AAV.php.b-husod1-sgrna decreases SOD1 in neonatal H11Cas9 SOD1G93A mice.

    “caused robust and sustained mutant huSOD1 protein reduction in the cortex and spinal cord”

    Animalsin neonatal H11Cas9 SOD1G93A miceintracerebroventricular injectioncortex and spinal cord

    In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

    Gene therapy

More on SOD1

Latest